EZH2 and hepatocellular carcinoma: Meanwhile, EZH2, another Polycomb-group (PcG) protein associated with histone modification of H3K27me3 (Figure 6C), showed no change in abundance, consistent with a study reporting that USP22 silencing did not change EZH2 in hepatocellular carcinoma [29].